Percutaneous coronary intervention using drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease an updated meta-analysis of randomized clinical trials.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 29029526)

Published in Oncotarget on August 10, 2017

Authors

Lei Gao1, Yuqi Liu1, Zhijun Sun1, Yabin Wang1, Feng Cao1, Yundai Chen1

Author Affiliations

1: Department of Cardiology, PLA General Hospital, Beijing 100853, China.

Articles cited by this

Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91

Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet (1994) 11.37

Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy (2002) 8.49

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet (2013) 4.34

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med (2016) 3.88

Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med (2011) 3.55

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet (2016) 2.61

Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation (2010) 2.40

Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study. J Am Coll Cardiol (2015) 1.92

Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol (2008) 1.70

Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry. J Am Coll Cardiol (2009) 1.65

Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients. JACC Cardiovasc Interv (2014) 1.44

Current management of left main coronary artery disease. Eur Heart J (2012) 1.34

Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation (1995) 1.32

Drug-eluting stents: a systematic review and economic evaluation. Health Technol Assess (2007) 1.10

Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. J Am Coll Cardiol (2011) 1.09

Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry. Circulation (1989) 1.02

Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes. J Am Coll Cardiol (2016) 0.87

Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis: A Meta-Analysis of Randomized Trials. Circ Cardiovasc Interv (2016) 0.84

Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease. J Am Coll Cardiol (2016) 0.81

Percutaneous coronary intervention with stent implantation versus coronary artery bypass surgery for treatment of left main coronary artery disease: is it time to change guidelines? Circ Cardiovasc Interv (2009) 0.78

Second versus first generation DES in multiple vessel disease and unprotected left main stenosis: insights from ERACI IV Study. Minerva Cardioangiol (2015) 0.78

Waldenstrom's macroglobulinaemia. J Assoc Physicians India (1990) 0.77

Update on percutaneous intervention for left main coronary artery stenosis. Expert Rev Cardiovasc Ther (2015) 0.77

Comparison of bypass surgery and drug-eluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies. Cardiol J (2014) 0.77

Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease. Am J Cardiol (2016) 0.77

Revascularization options: coronary artery bypass surgery and percutaneous coronary intervention. Cardiol Clin (2014) 0.77

Revascularization of unprotected left main coronary artery disease: strategy selection and systematic risk assessment. Catheter Cardiovasc Interv (2012) 0.77

Drug-eluting stent implantation for coronary artery disease: current stents and a comparison with bypass surgery. Curr Opin Pharmacol (2012) 0.76